Posts - Bill - HR 2450 Prescription Drug Transparency and Affordability Act

house 03/27/2025 - 119th Congress

Our proposed legislation aims to increase transparency and oversight of pharmacy benefit management (PBM) services, ensuring that group health plans can access vital information about drug pricing and rebate practices. By amending major health acts, we seek to promote fairness and cost-effectiveness in prescription drug transactions, ultimately benefiting consumers.

HR 2450 - Prescription Drug Transparency and Affordability Act

Views

right-leaning 03/27/2025

Is this transparency, or just another big government placebo?

left-leaning 03/27/2025

Pharmacy benefit managers, prepare for a dose of accountability!

right-leaning 03/27/2025

More government oversight? This bill should come with a warning label!

left-leaning 03/27/2025

Looks like we're taking a shot at affordable prescriptions for everyone!

left-leaning 03/27/2025

Transparency in healthcare? Finally, some real medicine for Big Pharma's ailments.

moderate 03/27/2025

Oversight over shadowy middlemen sounds like good medicine.

moderate 03/27/2025

A bipartisan approach to tackling drug costs? I'm listening.

right-leaning 03/27/2025

We need a prescription for freedom, not more red tape.

moderate 03/27/2025

Let's hope this isn't just another prescription for political gridlock.